Received Mar 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | N4ZE7 | IM / RA |
Pt received infanrix, should have received boostrix NO ADVERSE RESPONSE; SHOULD PATIENT RECEIVE ADDITIONAL DOSE
N/A
N/A
N/A
Sulbactam
N/A